Central Pontine Myelinolysis Secondary to Hyperglycemia: A Case Report

Central Pontine Myelinolysis, Diabetes Mellitus, Hyperglycemia

Authors

  • Walid Mohamed Moussa, MhD Emergency Department, Mohamed V Military Hospital, Rabat, Faculty of Medicine and Pharmacy of Rabat, University Mohammed V Souissi, Rabat, Mohammed V University in Rabat, Morocco
  • Ibtissam EL OUALI, MhD Radiology Department, University Hospital Ibn Sina, Rabat, Faculty of Medicine and Pharmacy of Rabat, University Mohammed V Souissi, Rabat, Mohammed V University in Rabat, Morocco
  • Aicha HOUSSEIN MOUSSA, MhD Emergency Department, Mohamed V Military Hospital, Rabat, Faculty of Medicine and Pharmacy of Rabat, University Mohammed V Souissi, Rabat, Mohammed V University in Rabat, Morocco
  • Tarek DENDANE Medical Intensive care Department, University Hospital Ibn Sina of Rabat, Faculty of Medicine and Pharmacy of Rabat, Mohammed V University in Rabat, Morocco
  • Amine Ali ZEGGWAGH, PhD Medical Intensive care Department, University Hospital Ibn Sina of Rabat, Faculty of Medicine and Pharmacy of Rabat, Mohammed V University in Rabat, Morocco
February 24, 2023

Downloads

Centropontine myelinolysis (MCP) belongs to the osmotic demyelination syndrome, and occurs especially after the rapid correction of hyponatremia. In rare cases, it is caused by states of hyperosmolarity and it can be seen in hyperglycemia.

Here, we report the case of a 32-year-old diabetic patient, admitted to intensive care unit for a disorder of consciousness and seizures.

The physical examination found an apyretic patient with, Glasgow at 11, with quadriparesis and high blood pressure. Laboratory investigations showed hyperglycemia and metabolic ketoacidosis with chronic renal failure, natremia was normal, lumbar puncture was also normal. The diagnosis of MCP was retained on the MRI.

Insulin therapy and rehydration were started and the patient showed a clinical improvement. However, he died because of ventilator-associated pneumonia.

The aim of this work is to show that MCP can occur in the absence of an abnormality of natremia and this diagnosis should be considered in diabetic patients with neurological disorders.